SynthesisPloS one2013
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011.
Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations.PLoS neglected tropical diseases · 2021Pooled it
- Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe.Parasites & vectors · 2018Pooled it
- Epidemiology and management of foodborne nematodiasis in the European Union, systematic review 2000-2016.Pathogens and global health · 2018Pooled it
- Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe.Parasites & vectors · 2017Pooled it
- PCR-Confirmed Convexity Subarachnoid Neurocysticercosis with Negative Serology: A Case Report.Pathogens (Basel, Switzerland) · 2026Article
- Article
- Autochthonous Neurocysticercosis Brain Lesions Mimicking Metastatic Disease, Spain.Emerging infectious diseases · 2026Article
- Occurrence of autochthonous neurocysticercosis in Germany: a case report.BMC infectious diseases · 2026Article
- Integrating neurological expertise into One Health strategies for pediatric neurocysticercosis-associated epilepsy control in Sub-Saharan Africa: a narrative review.One health outlook · 2025Review
- The hidden threat of cysticercosis: A neglected public health problem.Open veterinary journal · 2025Review
- Temporal trends and future projections of cysticercosis-induced epilepsy: insights from the global burden of disease study 2021- a cross-sectional study.Frontiers in public health · 2025Article
- Transclival endoscopic approach for prepontine cistern neurocysticercosis causing trigeminal neuralgia: illustrative case.Journal of neurosurgery. Case lessons · 2024Article
- Molecular diagnosis of Taenia saginata from two patients in Palestine: two case reports.Journal of medical case reports · 2024Article
- Insights into the diagnosis, vaccines, and control of Taenia solium, a zoonotic, neglected parasite.Parasites & vectors · 2023Review
- The Genomes of Two Strains ofFrontiers in cellular and infection microbiology · 2022Article
- Endoscopic endonasal surgery for massive subarachnoid neurocysticercosis: illustrative case.Journal of neurosurgery. Case lessons · 2021Article
- Case of Orbital Cysticercosis Presenting as Recurrent Cellulitis Diagnosed on Multi-Modality Imaging.Cureus · 2021Article
- Collaborative Studies for the Detection ofMicroorganisms · 2021Article
- Isolated Myocysticercosis of Anterior Chest Wall.Indian journal of pediatrics · 2021Article
- Taenia solium in the Anterior Chamber: Surgical Management of a Rare Case of Live Free-Floating Parasite.Case reports in ophthalmological medicine · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
Abstract
backgroundCysticercosis is caused by the invasion of human or pig tissues by the metacestode larval stage of Taenia solium. In Europe, the disease was endemic in the past but the autochthonous natural life cycle of the parasite is currently completed very rarely. Recently, imported cases have increased in parallel to the increased number of migrations and international travels. The lack of specific surveillance systems for cysticercosis leads to underestimation of the epidemiological and clinical impacts.
objectivesTo review the available data on epidemiology and management of cysticercosis in Europe.
methodsA review of literature on human cysticercosis and T. solium taeniasis in Europe published between 1990-2011 was conducted.
resultsOut of 846 cysticercosis cases described in the literature, 522 cases were autochthonous and 324 cases were imported. The majority (70.1%) of the autochthonous cases were diagnosed in Portugal from 1983 and 1994. Imported cases of which 242 (74.7%) diagnosed in migrants and 57 (17.6%) in European travellers, showed an increasing trend. Most of imported cases were acquired in Latin America (69.8% of migrants and 44.0% of travellers). The majority of imported cases were diagnosed in Spain (47.5%), France (16.7%) and Italy (8.3%). One third of neurosurgical procedures were performed because the suspected diagnosis was cerebral neoplasm. Sixty eight autochthonous and 5 imported T. solium taeniasis cases were reported.
conclusionsCysticercosis remains a challenge for European care providers, since they are often poorly aware of this infection and have little familiarity in managing this disease. Cysticercosis should be included among mandatory reportable diseases, in order to improve the accuracy of epidemiological information. European health care providers might benefit from a transfer of knowledge from colleagues working in endemic areas and the development of shared diagnostic and therapeutic processes would have impact on the quality of the European health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.